ArticleLeukemia2020

Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy.

G A Amos Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.